Tag Archives: Jason Mccarthy

Analysts Are Bullish on These Healthcare Stocks: Karuna Therapeutics (KRTX), Sensus Healthcare (SRTS)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Karuna Therapeutics (KRTX – Research Report) and Sensus Healthcare (SRTS – Research Report) with bullish sentiments. Karuna Therapeutics (KRTX) In a report

Maxim Group Reaffirms Their Buy Rating on Inmune Bio (INMB)

Maxim Group analyst Jason McCarthy maintained a Buy rating on Inmune Bio (INMB – Research Report) on March 26 and set a price target of $13.00. The company’s shares closed last Monday at $20.80. According to TipRanks.com, McCarthy is a

Maxim Group Keeps a Buy Rating on Heat Biologics (HTBX)

In a report issued on March 26, Jason McCarthy from Maxim Group maintained a Buy rating on Heat Biologics (HTBX – Research Report), with a price target of $14.00. The company’s shares closed last Monday at $8.37. According to TipRanks.com,

AIM ImmunoTech (AIM) Receives a Buy from Maxim Group

Maxim Group analyst Jason McCarthy maintained a Buy rating on AIM ImmunoTech (AIM – Research Report) on March 26 and set a price target of $2.00. The company’s shares closed last Monday at $2.58. According to TipRanks.com, McCarthy is a

Analysts Are Bullish on Top Healthcare Stocks: Antibe Therapeutics (ATBPF), Agenus (AGEN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Antibe Therapeutics (ATBPF – Research Report) and Agenus (AGEN – Research Report) with bullish sentiments. Antibe Therapeutics (ATBPF) In a report issued

Maxim Group Issues a Buy Rating on Matinas BioPharma (MTNB)

In a report released yesterday, Jason McCarthy from Maxim Group assigned a Buy rating to Matinas BioPharma (MTNB – Research Report), with a price target of $3.00. The company’s shares closed last Friday at $1.46. According to TipRanks.com, McCarthy is